Plasmakinetic Enucleation of the Prostate and Open Prostatectomy to Treat Large Prostates
Plasmakinetic Enucleation of the Prostate and Open Prostatectomy to Treat Large Prostates
The investigators hypothesize that Plasmakinetic Enucleation of the Prostate (PkEP) might
 yield functional results comparable to OP but with lower perioperative morbidity, and have
 equivalent long-term efficacy with OP for large prostates. The first objective was to
 demonstrate the non-inferiority of PKEP compared to OP concerning Qmax at one year
 postoperatively.

 To explore the long-term efficacy, we compared the efficacy, safety, and morbidity of PkEP
 with those of OP in BPH patients with prostate glands larger than 100 g over a follow-up
 period of 6 years.
Inclusion Criteria:

 -  •Qmax < 12 mL/s, IPSS >19

 -  Age between 50 and 70 years

 -  Prostate volume larger than 100 mL, as determined by TRUS post-void residual
 urine volume greater than 50 ml medical therapy failure.

 Exclusion Criteria:

 -  •severe pulmonary disease or heart disease, coagulopathy, neurogenic bladder, bladder
 calculus, bladder cancer, prostate cancer, urethral stricture and previous prostate or
 urethral surgery